Press Releases
Search
-
24 Feb 2021
bioMérieux – 2020 Financial Results
€3,118 million in full-year 2020 sales, up 19.7 % like-for-like Robust sales performance in the fourth quarter, with organic growth of 20.5 % led by sales of molecular biology reagents Contributive op...
-
03 Feb 2021
bioMérieux announces the CE marking of NEPHROCHECK® test on VIDAS®
Marcy l’Etoile, France – February 3rd , 2021 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced the CE marking of the innovative NEPHROCHECK® assay to detect kidney str...
-
16 Dec 2020
bioMérieux announces the CE marking of its molecular biology ARGENE® test for the simultaneous detection of SARS-CoV-2, influenza viruses A and B, and RSV and hMPV viruses
Marcy l’Etoile, France – December 16, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, has announced the expansion of its ARGENE® range for the real-time PCR (RT-PCR) detection ...
-
14 Dec 2020
Increased outlook for full-year 2020
Marcy l'Étoile, December 14, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its adjusted outlook for full-year 2020.
-
14 Dec 2020
The French bioproduction sector announces the creation of Campus Biotech Digital, a platform unique in the world for bioproduction training
An ambitious goal to develop the skills necessary for health independence...
-
02 Dec 2020
BIOASTER, Université de Technologie de Compiègne, Hospices Civils de Lyon and bioMérieux formalize strategic collaboration to conduct Next Generation Sequencing technology evaluation in microbiology
Lyon, December 2, 2020 - BIOASTER Microbiology Technology Research Institute announced a strategic partnership in the field of sequencing-based diagnostics in microbiology with the Université de Techn...
-
16 Nov 2020
bioMérieux announces the expansion of the CE marking of its molecular biology ARGENE® SARS-CoV-2 diagnostic test to include saliva specimens.
Marcy l’Etoile, France – November 16, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, has announced the expansion of its ARGENE® range for the detection of SARS-CoV-2. As a com...
-
22 Oct 2020
bioMérieux – Information financière du 3e trimestre 2020
Croissance organique de 19,4 % à taux de change et périmètre constants au terme des 9 premiers mois : 2 266 millions d’euros de chiffre d’affaires +17,5 % de croissance à données publiées Poursuite de...
-
22 Oct 2020
bioMérieux – Third-Quarter 2020 Business Review
Organic growth of 19.4% at constant exchange rates and scope of consolidation over the first nine months of the year: €2,266 million in sales Up 17.5% as reported Further exceptional momentum in the t...
-
08 Oct 2020
AMSP partners with bioMérieux to facilitate supply of high-quality COVID-19 diagnostics
bioMérieux and the Africa Medical Supplies Platform (AMSP), have announced a new partnership to facilitate the supply of high-quality diagnostic solutions from the bioMérieux Pandemic Response Portfol...
-
02 Sep 2020
First-Half 2020 Results
Organic sales growth of 15.7% in first-half 2020: €1,476 million in sales Up 15.8% as reported As expected, a mixed sales performance, with faster momentum in molecular biology solutions contrasting w...
-
16 Jul 2020
Launch of BIOFIRE® MYCOPLASMA test for mycoplasma detection in biopharmaceutical products
bioMérieux, a world leader in the field of in vitro diagnostics, has announced the launch of BIOFIRE® MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biothe...
-
09 Jul 2020
Second-Quarter 2020 Business Performance Preannouncement
In light of the withdrawal of its annual objectives, bioMérieux, a world leader in the field of in vitro diagnostics, today announced preliminary quarterly information about its business activity endi...
-
29 Jun 2020
bioMérieux issues a €200 million Euro PP bond
Marcy l’Étoile (France) - June 29, 2020 – bioMérieux, a global leader in the field of in vitro diagnostics, announces that it has successfully issued today a €200 million Euro PP new debt with a top-t...
-
15 Jun 2020
BIOFIRE® Respiratory Panel 2.1 plus with SARS-CoV-2 is CE marked
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that the BIOFIRE® Respiratory Panel 2.1 plus (RP2.1plus) is CE marked. The BIOFIRE® Respiratory Panel 2.1 plus (RP2.1pl...